VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

DISEASE CHARACTERISTICS: * Histologically confirmed incurable primary or metastatic solid tumor or non-Hodgkin's lymphoma * Relapsed after or is refractory (e.g., unresectable) to at least 2 standard chemotherapy regimens and rituximab * No standard curative surgery, chemotherapy, immunotherapy, other antitumor therapy, or radiotherapy options exist * No known or suspected squamous cell carcinoma of the lung * No prior or concurrent CNS (brain or leptomeningeal) metastases * No prior or concurrent primary intracranial tumor by MRI or CT scan PATIENT CHARACTERISTICS: Age: * 25 and over Performance status: * ECOG 0-2 Life expectancy: * Not specified Hematopoietic: * WBC at least 3,500/mm\^3 * Absolute neutrophil count at least 1,500/mm\^3 * Platelet count at least 100,000/mm\^3 * Hemoglobin at least 9.0 g/dL * No other severe or uncontrolled hematologic condition Hepatic: * Bilirubin no greater than 1.5 times upper limit of normal (ULN) * AST and ALT no greater than 2 times ULN * Alkaline phosphatase no greater than 2 times ULN * PT, PTT, and INR normal Renal: * Creatinine no greater than ULN * No 1+ or greater proteinuria * No other severe or uncontrolled renal condition Cardiovascular: * Electrocardiogram normal * LVEF normal by echocardiogram or MUGA scan within the past 12 months or since completion of prior anthracycline * No severe or uncontrolled cardiovascular condition * No New York Heart Association class III or IV heart disease * No active corona…